Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan J Magaña

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Journal of Neuroscience Research|January 25, 2011
Perspectives on gene therapy in myotonic dystrophy type 1Jonathan J Magaña, Bulmaro Cisneros
Gaceta Medica De Mexico|January 16, 2010
[Pathogenesis of myotonic dystrophy type 1]Jonathan J Magaña, Norberto Leyva-García, Bulmaro Cisneros
The AAPS Journal|November 19, 2024
Glycyrrhizic Acid Formulated in Hydrotalcite Nanocarriers Intended to Act as a Hepatoprotective AgentMagali Hernández, Enrique Lima, Jonathan J Magaña, et al.
Archives of Medical Research|July 30, 2008
Association of interleukin-6 gene polymorphisms with bone mineral density in Mexican womenJonathan J Magaña, Rocío Gómez, Bulmaro Cisneros, et al.
Revista Medica De Chile|October 6, 2009
[Capillary electrophoresis, a new diagnostic tool]Jonathan J Magaña, María de la Luz Arenas-Sordo, Rocío Gómez Ortega
BMC Chemistry|August 7, 2019
New copolymers as hosts of ribosomal RNAMagali Hernández, Gerardo Leyva, Jonathan J Magaña, et al.
Drug Discovery Today|February 22, 2015
Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brainGerardo Leyva-Gómez, Hernán Cortés, Jonathan J Magaña, et al.
Burns : Journal of the International Society for Burn Injuries|May 27, 2018
From traditional biochemical signals to molecular markers for detection of sepsis after burn injuriesBalam Muñoz, Rocío Suárez-Sánchez, Oscar Hernández-Hernández, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|September 16, 2023
Recombinant Antibodies to Face SARS-CoV-2 SyndemicMaykel González Torres, Gerardo Leyva Gómez, María Luisa Del Prado-Audelo, et al.
International Journal of Molecular Sciences|August 10, 2024
Specific Biomarkers in Spinocerebellar Ataxia Type 3: A Systematic Review of Their Potential Uses in Disease Staging and Treatment AssessmentAlexandra E Soto-Piña, Caroline C Pulido-Alvarado, Jaroslaw Dulski, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Journal of Neuroscience Research|January 25, 2011
Perspectives on gene therapy in myotonic dystrophy type 1Jonathan J Magaña, Bulmaro Cisneros
Gaceta Medica De Mexico|January 16, 2010
[Pathogenesis of myotonic dystrophy type 1]Jonathan J Magaña, Norberto Leyva-García, Bulmaro Cisneros
The AAPS Journal|November 19, 2024
Glycyrrhizic Acid Formulated in Hydrotalcite Nanocarriers Intended to Act as a Hepatoprotective AgentMagali Hernández, Enrique Lima, Jonathan J Magaña, et al.
Archives of Medical Research|July 30, 2008
Association of interleukin-6 gene polymorphisms with bone mineral density in Mexican womenJonathan J Magaña, Rocío Gómez, Bulmaro Cisneros, et al.
Revista Medica De Chile|October 6, 2009
[Capillary electrophoresis, a new diagnostic tool]Jonathan J Magaña, María de la Luz Arenas-Sordo, Rocío Gómez Ortega
BMC Chemistry|August 7, 2019
New copolymers as hosts of ribosomal RNAMagali Hernández, Gerardo Leyva, Jonathan J Magaña, et al.
Drug Discovery Today|February 22, 2015
Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brainGerardo Leyva-Gómez, Hernán Cortés, Jonathan J Magaña, et al.
Burns : Journal of the International Society for Burn Injuries|May 27, 2018
From traditional biochemical signals to molecular markers for detection of sepsis after burn injuriesBalam Muñoz, Rocío Suárez-Sánchez, Oscar Hernández-Hernández, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|September 16, 2023
Recombinant Antibodies to Face SARS-CoV-2 SyndemicMaykel González Torres, Gerardo Leyva Gómez, María Luisa Del Prado-Audelo, et al.
International Journal of Molecular Sciences|August 10, 2024
Specific Biomarkers in Spinocerebellar Ataxia Type 3: A Systematic Review of Their Potential Uses in Disease Staging and Treatment AssessmentAlexandra E Soto-Piña, Caroline C Pulido-Alvarado, Jaroslaw Dulski, et al.
Pageof 9